Sonoma Pharmaceuticals Inc

NASDAQ:SNOAUnited States

Sonoma Pharmaceuticals, Inc. is a global healthcare company, which is engaged in developing and producing stabilized hypochlorous acid (HOCl), products for a range of applications, including wound care, eye care, oral care, dermatological conditions, podiatry, animal health care and non-toxic disinfectants. The Company's product offerings include Lumacyn Clarifying Mist; Regenacyn Advanced Scar Gel; Reliefacyn Advanced Itch-Burn-Rash-Pain Relief Hydrogel; Microcyn OTC Advanced Wound & Skin Cleanser; Podiacyn Advanced Everyday Foot Care, MicrocynAH and others. Lumacyn Clarifying Mist is intended for use as a daily skin toner, to soothe and cleanse the skin, reduce redness, and manage blemishes by reducing infection. Podiacyn is intended for management of foot odors, infections, and irritations, as well as daily foot health and hygiene. MicrocynAH is an HOCl-based topical product that cleans, debrides and treats a range of animal wounds and infections.

Contact Information

Headquarters

5445 CONESTOGA COURT, SUITE 150BOULDER, CO, United States 80301

Phone

617-243-0050

Fax

707-283-0551

Executives

Chief Executive Officer, Director

Amy Trombly

Chief Financial Officer

Jerry Dvonch

Chief Operating Officer, Executive Vice President, Corporate Secretary

Bruce Thornton

Lead Independent Director

Jerry Mclaughlin

Independent Director

Jay Birnbaum